- Home
- SFST vs MXCT Comparison
SFST vs MXCT Comparison
Compare SFST & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- MXCT
- Stock Information
- Founded
- SFST 1999
- MXCT 1999
- Country
- SFST United States
- MXCT United States
- Employees
- SFST N/A
- MXCT N/A
- Industry
- SFST Major Banks
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SFST Finance
- MXCT Health Care
- Exchange
- SFST Nasdaq
- MXCT Nasdaq
- Market Cap
- SFST 285.9M
- MXCT 239.2M
- IPO Year
- SFST 1999
- MXCT 2021
- Fundamental
- Price
- SFST $39.38
- MXCT $2.24
- Analyst Decision
- SFST Buy
- MXCT Strong Buy
- Analyst Count
- SFST 1
- MXCT 1
- Target Price
- SFST $43.00
- MXCT $9.00
- AVG Volume (30 Days)
- SFST 15.9K
- MXCT 856.8K
- Earning Date
- SFST 07-17-2025
- MXCT 08-05-2025
- Dividend Yield
- SFST N/A
- MXCT N/A
- EPS Growth
- SFST 37.29
- MXCT N/A
- EPS
- SFST 2.25
- MXCT N/A
- Revenue
- SFST $97,501,000.00
- MXCT $37,675,000.00
- Revenue This Year
- SFST $4.07
- MXCT $8.82
- Revenue Next Year
- SFST $8.99
- MXCT $21.12
- P/E Ratio
- SFST $17.37
- MXCT N/A
- Revenue Growth
- SFST 11.95
- MXCT N/A
- 52 Week Low
- SFST $27.65
- MXCT $2.00
- 52 Week High
- SFST $45.91
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- SFST 64.65
- MXCT 49.25
- Support Level
- SFST $35.15
- MXCT $2.13
- Resistance Level
- SFST $40.09
- MXCT $2.32
- Average True Range (ATR)
- SFST 1.02
- MXCT 0.12
- MACD
- SFST 0.30
- MXCT 0.02
- Stochastic Oscillator
- SFST 86.58
- MXCT 75.95
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.